Down Syndrome
Neurology·MeSH: Down Syndrome
Prevalence
75.0 / 100K
2 drugs in development·2 companies·9 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Down Syndrome?
BioSniper tracks 2 drugs in development for Down Syndrome across 2 companies.
How many clinical trials target Down Syndrome?
There are 9 clinical trials targeting Down Syndrome tracked by BioSniper.
What is the prevalence of Down Syndrome?
The estimated prevalence of Down Syndrome is approximately 75.0 per 100,000 population.
Deep-dive into Down Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis